Developer docs
API playgroundTry for free, no card

Search company profiles

Motion Informatics

Full company profile

uuid000wag5

Namestring
Motion Informatics
Legal namestring
Motion Informatics Ltd.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Motion Informatics Ltd. is an Israel-based medical technology company founded in 2014 that builds AI-driven adaptive neuromuscular stimulation platforms for stroke and neurological rehabilitation. Its product portfolio centers on three systems sharing the proprietary BioRhythmIQ signal processing architecture: STIMEL-03, an FDA-cleared EMG-triggered closed-loop stimulation device with up to 8 stimulation channels and adaptive threshold control; Spatial StimelMD (SSMD), a next-generation platform integrating AR biofeedback, FES/NMES, and cloud-based remote patient monitoring with Therapist (SSMD-T), Home (SSMD-H), and Remote (SSMD-R) deployment variants; and Axionis-Kynara, an in-development predictive neurorehabilitation platform incorporating Brain-Computer Interface technology.

The core technology fuses real-time electrophysiology, adaptive stimulation, and spatial computing to detect voluntary motor intent and deliver precisely timed, intent-triggered stimulation. Proprietary algorithms decode neuromuscular intent at a 2,000 Hz sampling rate with sub-8ms trigger latency and sensitivity down to 10-30 microvolts, enabling detection of sub-visible descending neural drive. The platform operates on three AI levels — real-time signal interpretation, longitudinal trend analysis, and structured clinical reporting — and is anchored by US Patent No. 7,221,980 B2. STIMEL-03 holds FDA Breakthrough Device Designation, while Spatial StimelMD is under FDA 510(k) and CE-MDR review.

The company monetizes primarily through hardware sales of clinical-grade devices, supplemented by recurring cloud and remote-monitoring subscriptions on AWS infrastructure. Its go-to-market combines direct enterprise sales for hospitals and rehabilitation centers with a channel-first model: 40+ certified regional distributors with exclusive territory rights span four continents, and an exclusive U.S. distribution partnership with ReShape Lifesciences was signed in September 2025. Customer segments include hospitals and rehabilitation clinics (primary), home healthcare users, physicians and physical therapists, and regional medical technology distributors. Pricing is quote-based, undisclosed publicly, and structured around multi-year enterprise contracts.

Short descriptiontext

Motion Informatics Ltd. is an Israel-based medical technology company that develops AI-driven, EMG-triggered neuromuscular stimulation platforms (STIMEL-03, Spatial StimelMD, Axionis-Kynara) for hospitals, rehabilitation clinics, and home users treating stroke and neurological injury.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHaifa, Israel
HQ citystring
Haifa
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neuromuscular rehabilitation devices, functional electrical stimulation, EMG biofeedback therapy, stroke rehabilitation technology, adaptive neurostimulation systems
Industry4 codes
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHSABADAN
Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home
Home & Personal Services/Elder Care & In-Home Care Services/Rehabilitation Therapy (PT/OT/SLP) In-Home
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Home Health Care Services62161
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Neuromuscular Rehabilitation Medical Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of FDA-cleared and CE-MDR submitted neuromuscular stimulation devices including STIMEL-03 and Spatial StimelMD. Devices are sold to clinical centers, hospitals, and directly to patients for home use, representing the primary revenue stream.

motioninformatics.ai
2Cloud Services & Data Platform
TypeSubscription Recurring
Description

Associated cloud services for rehabilitation session data storage, therapist monitoring, and remote patient monitoring via the SSMD platform. AWS-based secure data storage and processing infrastructure supports ongoing service revenue.

motioninformatics.ai
3Distributor Partnership Revenue
TypeHardware Sales
Description

Revenue generated through distributor network partnerships including exclusive territory arrangements, with competitive distributor pricing, volume incentives, and performance-based rebate structures.

motioninformatics.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain
Pricing details1 tier
1Enterprise/Clinic Deployment - Professional clinical-grade devices for hospitals and rehabilitation centers
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing; contact sales for clinical demonstration and custom quotation based on facility requirements and deployment scale.

motioninformatics.ai
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1STIMEL-03
Description

FDA-cleared intelligent closed-loop neuromuscular stimulation system for post-stroke and neurological rehabilitation with EMG-triggered stimulation, adaptive threshold control, and multi-channel precision.

motioninformatics.ai
+3 more records
Core offering1 text field

Motion Informatics designs, develops, and sells AI-driven adaptive neuromuscular stimulation medical devices for post-stroke and neurological rehabilitation. Its products combine real-time EMG biofeedback, Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), augmented reality biofeedback, and proprietary BioRhythmIQ adaptive signal processing to decode patient motor intent and deliver intent-triggered therapy across clinical and home settings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Recovery is 2.3x faster than controls with fewer sessions
+6 more records
Product overview1 text field

Motion Informatics builds a unified computational treatment platform that fuses real-time electrophysiology, adaptive stimulation, and spatial computing for neuromuscular rehabilitation. The portfolio centers on three products: the FDA-cleared STIMEL-03 as the flagship EMG-triggered stimulation device; the next-generation Spatial StimelMD (SSMD) platform adding AI-powered analytics and AR immersive biofeedback with therapist, home, and remote deployment variants; and the Axionis-Kynara (in development) as a predictive neurorehabilitation module incorporating Brain-Computer Interface technology. All products share the proprietary BioRhythmIQ adaptive threshold technology and closed-loop control architecture.

Product and service3 records
1STIMEL-03
CategoryNeuromuscular Rehabilitation Medical Device
Description

FDA-cleared, EMG-driven intelligent closed-loop neuromuscular stimulation system integrating Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), and real-time biofeedback. Powered by BioRhythmIQ technology, it captures electromyographic signals, analyzes neuromotor intent in real time, and delivers intent-triggered stimulation to reinforce correct motor activation patterns in post-stroke and neurological rehabilitation for hospitals, rehabilitation centers, and physical therapy clinics.

2Spatial StimelMD (SSMD)
CategoryAI/AR-Integrated Rehabilitation Platform
Description

Next-generation neuromuscular rehabilitation platform integrating AI, Augmented Reality (AR), FES, NMES, real-time biofeedback, and BioRhythmIQ technology into a unified adaptive clinical ecosystem. Includes SSMD-T (Therapist Unit), SSMD-H (Home Unit), and SSMD-R (Remote Module) variants supporting immersive AR therapy, AI-driven adaptation, multi-modal stimulation, and remote patient monitoring for clinicians and home users.

3Axionis-Kynara
CategoryBrain-Computer Interface Neurorehabilitation Platform
Description

AI-powered predictive neurorehabilitation platform combining AI, AR, FES, NMES, real-time biofeedback, Brain-Computer Interface (BCI), and BioRhythmIQ technology. Designed to decode patient intent in real time and deliver predictive stimulation before movement is fully expressed for personalized motor recovery from stroke, spinal cord injury, and traumatic brain injury.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-04
Description

ReShape Lifesciences entered an exclusive U.S. distribution agreement with Motion Informatics to market the FDA-cleared Stimel-03 neuromuscular rehabilitation device and Spatial StimelMD system. The partnership expands ReShape's portfolio beyond weight-loss and metabolic health solutions into neurorehabilitation, leveraging their established commercial reach to distribute AI and AR-enabled rehabilitation technology across the U.S. market.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology, with FES and neurostimulation offerings that overlap with Motion Informatics' clinical rehabilitation focus.

TypeEmerging player
Description

Myomo offers myoelectric orthoses that use EMG signals to assist arm movement, closely related to Motion Informatics' EMG-triggered neuromuscular stimulation concept for stroke patients.

TypeDirect peer
Description

Bioness (acquired by Bioventus) is a direct competitor in functional electrical stimulation (FES) devices for stroke and orthopedic rehabilitation, with overlapping L300 Go and H200 Wireless products serving the same clinical use cases as STIMEL-03.

TypeBroad incumbent
Description

NeuroPace is an implantable neuromodulation company (RNS System) for epilepsy, broadly comparable as a neurotechnology platform with FDA-cleared neurostimulation hardware.

TypeDirect peer
Description

Saebo specializes in upper-limb stroke rehabilitation devices and orthoses, directly competing with Motion Informatics in the post-stroke motor recovery clinic and home segments targeted by SSMD-T and SSMD-H.

TypeEmerging player
Description

ReWalk develops wearable robotic exoskeletons for spinal cord injury and stroke rehabilitation, an adjacent technology competing for the same hospital/clinic rehab budgets.

TypeEmerging player
Description

Ekso Bionics develops wearable exoskeletons for stroke and spinal cord injury rehabilitation, competing with Motion Informatics in the clinic-based neuro-rehab capital equipment segment.

8Hocoma (DIH Medical)
TypeDirect peer
Description

DIH/Hocoma provides robotic and sensor-based rehabilitation technologies (Lokomat, Armeo) for clinics and hospitals, competing for the same neurorehabilitation budgets as Motion Informatics' Spatial StimelMD.

TypeDirect peer
Description

Tyromotion builds computer-assisted rehabilitation devices for upper and lower extremities, closely comparable to Motion Informatics' AR-integrated, multi-modal SSMD platform in stroke and neuro rehab clinics.

TypeDirect peer
Description

Restorative Therapies provides FES-based cycling and rehab systems (RT300, Xcite) for neurological recovery, directly comparable to Motion Informatics' intent-triggered NMES/FES approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Motion Informatics

Neuromuscular Rehabilitation Medical Devicesmotioninformatics.ai

Motion Informatics Ltd. is an Israel-based medical technology company that develops AI-driven, EMG-triggered neuromuscular stimulation platforms (STIMEL-03, Spatial StimelMD, Axionis-Kynara) for hospitals, rehabilitation clinics, and home users treating stroke and neurological injury.

What Motion Informatics does

Motion Informatics Ltd. is an Israel-based medical technology company founded in 2014 that builds AI-driven adaptive neuromuscular stimulation platforms for stroke and neurological rehabilitation. Its product portfolio centers on three systems sharing the proprietary BioRhythmIQ signal processing architecture: STIMEL-03, an FDA-cleared EMG-triggered closed-loop stimulation device with up to 8 stimulation channels and adaptive threshold control; Spatial StimelMD (SSMD), a next-generation platform integrating AR biofeedback, FES/NMES, and cloud-based remote patient monitoring with Therapist (SSMD-T), Home (SSMD-H), and Remote (SSMD-R) deployment variants; and Axionis-Kynara, an in-development predictive neurorehabilitation platform incorporating Brain-Computer Interface technology.

The core technology fuses real-time electrophysiology, adaptive stimulation, and spatial computing to detect voluntary motor intent and deliver precisely timed, intent-triggered stimulation. Proprietary algorithms decode neuromuscular intent at a 2,000 Hz sampling rate with sub-8ms trigger latency and sensitivity down to 10-30 microvolts, enabling detection of sub-visible descending neural drive. The platform operates on three AI levels — real-time signal interpretation, longitudinal trend analysis, and structured clinical reporting — and is anchored by US Patent No. 7,221,980 B2. STIMEL-03 holds FDA Breakthrough Device Designation, while Spatial StimelMD is under FDA 510(k) and CE-MDR review.

The company monetizes primarily through hardware sales of clinical-grade devices, supplemented by recurring cloud and remote-monitoring subscriptions on AWS infrastructure. Its go-to-market combines direct enterprise sales for hospitals and rehabilitation centers with a channel-first model: 40+ certified regional distributors with exclusive territory rights span four continents, and an exclusive U.S. distribution partnership with ReShape Lifesciences was signed in September 2025. Customer segments include hospitals and rehabilitation clinics (primary), home healthcare users, physicians and physical therapists, and regional medical technology distributors. Pricing is quote-based, undisclosed publicly, and structured around multi-year enterprise contracts.

Motion Informatics firmographics

Firmographics
Name
Motion Informatics
Legal name
Motion Informatics Ltd.
Website
https://motioninformatics.ai
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Motion Informatics Ltd. is an Israel-based medical technology company that develops AI-driven, EMG-triggered neuromuscular stimulation platforms (STIMEL-03, Spatial StimelMD, Axionis-Kynara) for hospitals, rehabilitation clinics, and home users treating stroke and neurological injury.
Ownership category
akta.pro rank

Motion Informatics industry classification

Industry
Product category
Neuromuscular Rehabilitation Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHSABADAN
Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home
Home & Personal Services/Elder Care & In-Home Care Services/Rehabilitation Therapy (PT/OT/SLP) In-Home

Keywords

  • Neuromuscular rehabilitation devices
  • Functional electrical stimulation
  • EMG biofeedback therapy
  • Stroke rehabilitation technology
  • Adaptive neurostimulation systems

Where Motion Informatics is headquartered

Location

Headquarters

HQ city
Haifa
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Motion Informatics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

  1. Medical Device Sales: Sale of FDA-cleared and CE-MDR submitted neuromuscular stimulation devices including STIMEL-03 and Spatial StimelMD. Devices are sold to clinical centers, hospitals, and directly to patients for home use, representing the primary revenue stream.
  2. Cloud Services & Data Platform: Associated cloud services for rehabilitation session data storage, therapist monitoring, and remote patient monitoring via the SSMD platform. AWS-based secure data storage and processing infrastructure supports ongoing service revenue.
  3. Distributor Partnership Revenue: Revenue generated through distributor network partnerships including exclusive territory arrangements, with competitive distributor pricing, volume incentives, and performance-based rebate structures.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/Clinic Deployment - Professional clinical-grade devices for hospitals and rehabilitation centers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Motion Informatics product offering

Product offering

Core offering

Motion Informatics designs, develops, and sells AI-driven adaptive neuromuscular stimulation medical devices for post-stroke and neurological rehabilitation. Its products combine real-time EMG biofeedback, Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), augmented reality biofeedback, and proprietary BioRhythmIQ adaptive signal processing to decode patient motor intent and deliver intent-triggered therapy across clinical and home settings.

Product overview

Motion Informatics builds a unified computational treatment platform that fuses real-time electrophysiology, adaptive stimulation, and spatial computing for neuromuscular rehabilitation. The portfolio centers on three products: the FDA-cleared STIMEL-03 as the flagship EMG-triggered stimulation device; the next-generation Spatial StimelMD (SSMD) platform adding AI-powered analytics and AR immersive biofeedback with therapist, home, and remote deployment variants; and the Axionis-Kynara (in development) as a predictive neurorehabilitation module incorporating Brain-Computer Interface technology. All products share the proprietary BioRhythmIQ adaptive threshold technology and closed-loop control architecture.

Differentiator

Problem solved

Functional benefit

Brands

  • STIMEL-03: FDA-cleared intelligent closed-loop neuromuscular stimulation system for post-stroke and neurological rehabilitation with EMG-triggered stimulation, adaptive threshold control, and multi-channel precision.
  • Spatial StimelMD
  • Axionis-Kynara
  • BioRhythmIQ

Products and services

  • STIMEL-03 FDA-cleared, EMG-driven intelligent closed-loop neuromuscular stimulation system integrating Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), and real-time biofeedback. Powered by BioRhythmIQ technology, it captures electromyographic signals, analyzes neuromotor intent in real time, and delivers intent-triggered stimulation to reinforce correct motor activation patterns in post-stroke and neurological rehabilitation for hospitals, rehabilitation centers, and physical therapy clinics.
  • Spatial StimelMD (SSMD) Next-generation neuromuscular rehabilitation platform integrating AI, Augmented Reality (AR), FES, NMES, real-time biofeedback, and BioRhythmIQ technology into a unified adaptive clinical ecosystem. Includes SSMD-T (Therapist Unit), SSMD-H (Home Unit), and SSMD-R (Remote Module) variants supporting immersive AR therapy, AI-driven adaptation, multi-modal stimulation, and remote patient monitoring for clinicians and home users.
  • Axionis-Kynara AI-powered predictive neurorehabilitation platform combining AI, AR, FES, NMES, real-time biofeedback, Brain-Computer Interface (BCI), and BioRhythmIQ technology. Designed to decode patient intent in real time and deliver predictive stimulation before movement is fully expressed for personalized motor recovery from stroke, spinal cord injury, and traumatic brain injury.

Quantifiable outcome

  • Recovery is 2.3x faster than controls with fewer sessions
  • +6 more outcomes

Companies that use Motion Informatics

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Motion Informatics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Motion Informatics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ReShape LifesciencescoreChannel Partner/ Reseller/ Distributor · 4 September 2025ReShape Lifesciences entered an exclusive U.S. distribution agreement with Motion Informatics to market the FDA-cleared Stimel-03 neuromuscular rehabilitation device and Spatial StimelMD system. The partnership expands ReShape's portfolio beyond weight-loss and metabolic health solutions into neurorehabilitation, leveraging their established commercial reach to distribute AI and AR-enabled rehabilitation technology across the U.S. market.

Scale indicators7 records

Recent moves8 records

Expansion highlights7 records

Motion Informatics competitors and assessment

Company assessment

Broad incumbents

  • Ottobock: Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology, with FES and neurostimulation offerings that overlap with Motion Informatics' clinical rehabilitation focus.
  • NeuroPace: NeuroPace is an implantable neuromodulation company (RNS System) for epilepsy, broadly comparable as a neurotechnology platform with FDA-cleared neurostimulation hardware.

Emerging players

  • Myomo: Myomo offers myoelectric orthoses that use EMG signals to assist arm movement, closely related to Motion Informatics' EMG-triggered neuromuscular stimulation concept for stroke patients.
  • ReWalk Robotics: ReWalk develops wearable robotic exoskeletons for spinal cord injury and stroke rehabilitation, an adjacent technology competing for the same hospital/clinic rehab budgets.
  • Ekso Bionics: Ekso Bionics develops wearable exoskeletons for stroke and spinal cord injury rehabilitation, competing with Motion Informatics in the clinic-based neuro-rehab capital equipment segment.

Direct peers

  • Bioness (Bioventus): Bioness (acquired by Bioventus) is a direct competitor in functional electrical stimulation (FES) devices for stroke and orthopedic rehabilitation, with overlapping L300 Go and H200 Wireless products serving the same clinical use cases as STIMEL-03.
  • Saebo: Saebo specializes in upper-limb stroke rehabilitation devices and orthoses, directly competing with Motion Informatics in the post-stroke motor recovery clinic and home segments targeted by SSMD-T and SSMD-H.
  • Hocoma (DIH Medical): DIH/Hocoma provides robotic and sensor-based rehabilitation technologies (Lokomat, Armeo) for clinics and hospitals, competing for the same neurorehabilitation budgets as Motion Informatics' Spatial StimelMD.
  • Tyromotion: Tyromotion builds computer-assisted rehabilitation devices for upper and lower extremities, closely comparable to Motion Informatics' AR-integrated, multi-modal SSMD platform in stroke and neuro rehab clinics.
  • Restorative Therapies: Restorative Therapies provides FES-based cycling and rehab systems (RT300, Xcite) for neurological recovery, directly comparable to Motion Informatics' intent-triggered NMES/FES approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Motion Informatics social profiles

Digital presence

Motion Informatics compliance and trust

Trust signal

Compliance2 records

Motion Informatics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Motion Informatics leadership team

Management profile

Number of profiles

Profiles2 records

Motion Informatics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Motion Informatics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Motion Informatics

What does Motion Informatics do?

Motion Informatics designs, develops, and sells AI-driven adaptive neuromuscular stimulation medical devices for post-stroke and neurological rehabilitation. Its products combine real-time EMG biofeedback, Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), augmented reality biofeedback, and proprietary BioRhythmIQ adaptive signal processing to decode patient motor intent and deliver intent-triggered therapy across clinical and home settings.

Is Motion Informatics a public or private company?

Motion Informatics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Motion Informatics founded?

Motion Informatics was founded in 2014. It employs 1 to 10 people.

Where is Motion Informatics based?

Motion Informatics is headquartered in Haifa, Israel, in the Middle East region.

How does Motion Informatics make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are cloud Services & Data Platform and distributor Partnership Revenue.

Who are Motion Informatics's main competitors?

Broad incumbents on record are Ottobock and NeuroPace. Emerging players are Myomo, ReWalk Robotics and Ekso Bionics. Direct peers are Bioness (Bioventus), Saebo, Hocoma (DIH Medical), Tyromotion and Restorative Therapies.

Does Motion Informatics have an API?

No public API is recorded for Motion Informatics.

What industry is Motion Informatics in?

Motion Informatics's product category is Neuromuscular Rehabilitation Medical Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Centerforsocialcapital10 Business Leaders Who Empower – and Help Their Companies Win in Tough TimesThis feature article from the Center for Social Capital profiles 10 business leaders to argue that employee empowerment is essential for resilience and long-term business success, citing supporting research from McKinsey, Deloitte, Cisco, the Agile Business Consortium, and the World Economic Forum. The article presents case studies from leaders at LifeGuides, Delta Air Lines, e.l.f. Beauty, Televerde, AIM Training and Consulting, Moka Origins, Motion Informatics LTD, Menlo Innovations, and SuperBetter, alongside Northern Illinois University, demonstrating how companies that empower employees through trust, autonomy, and well-being outperform control-based models.BusinessLineBiorad Medisys announces investments and product development in neurovascular, peripheral vascular segmentsBiorad Medisys, an Indian medical technology company, has announced strategic investments in the neurovascular and peripheral vascular segments, including an investment in Belgium-based Frid Mind Technologies and a 10% stake acquisition in Israel-based Motion Informatics Ltd. FMT has developed a patented stroke-prevention product using advanced braiding technology that has completed preclinical trials and first-in-human cases, while Motion Informatics manufactures the FDA-approved Stimel-03 stroke rehabilitation device for which Biorad holds manufacturing and distribution rights in select geographies including India and the US.Investing.comReShape secures exclusive deal for neuromuscular rehab tech By Investing.comReShape Lifesciences has entered an exclusive U.S. distribution agreement with Motion Informatics to market the FDA-cleared Stimel-03, a neuromuscular rehabilitation device combining Functional Electrical Stimulation, Neuromuscular Electrical Stimulation, and real-time EMG biofeedback for patient recovery from strokes, injuries, or surgeries. The partnership expands ReShape's portfolio beyond its weight-loss and metabolic health solutions into neurorehabilitation, with Motion Informatics' CEO expressing confidence in ReShape's commercial reach to distribute their AI and augmented reality-enabled Spatial StimelMD system across the U.S.BenzingaPenny Stock ReShape To Distribute FDA-Cleared Neuromuscular Device In USReShape Lifesciences (NASDAQ:RSLS) signed an exclusive agreement with Motion Informatics to import and distribute the FDA-cleared Stimel-03 neuromuscular rehabilitation device in the United States, marking the company's expansion into rehabilitation technology. The partnership combines ReShape's commercial infrastructure with Motion Informatics' rehabilitation technologies, as showcased at the 2025 AOTA Annual Conference. Separately, ReShape reported 2024 revenue of $8 million, down 7.7% from 2023, with the decline attributed to GLP-1 pharmaceutical competition impacting its Lap-Band business.BenzingaWhy ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket - AntShares of ReShape Lifesciences Inc. rose over 82% in pre-market trading following an announcement that the company has partnered with Motion Informatics to exclusively import and distribute neuromuscular rehabilitation devices in the US. The article also lists various other stocks experiencing significant price movements, including gains for Wheeler Real Estate Investment Trust and losses for Venus Concept Inc due to a registered direct offering.The Manila TimesReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. MarketReShape Lifesciences signed an exclusive U.S. distribution agreement with Motion Informatics to import and distribute neuromuscular rehabilitation devices, including the FDA-cleared Stimel-03. The partnership aims to bring AI-driven neurorehabilitation technology to the U.S. market, with Motion Informatics' Spatial StimelMD platform combining AI, EMG biofeedback, and augmented reality.GlobeNewswireReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. MarketReShape Lifesciences signed an agreement with Motion Informatics to exclusively import and distribute their neuromuscular rehabilitation devices in the U.S. The flagship product, Stimel-03, integrates FES, NMES, and EMG biofeedback, while Spatial StimelMD combines AI-driven neuromodulation with augmented reality. The partnership aims to expand ReShape's product portfolio beyond weight loss.YahooReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. MarketReShape Lifesciences signed an exclusive U.S. distribution agreement with Motion Informatics to import and distribute neuromuscular rehabilitation devices, including the FDA-cleared Stimel-03. The partnership aims to bring AI-driven, real-time EMG biofeedback technology to U.S. clinics and home settings.Investing.comReShape secures exclusive deal for neuromuscular rehab tech By Investing.comReShape Lifesciences signed an exclusive distribution agreement with Motion Informatics to bring neuromuscular rehab devices to the U.S. market. The company reported a market cap of $1.13 million, annual revenue of $8.01 million, and a 63.17% gross margin. The partnership aims to expand availability of neuromuscular rehabilitation solutions.FinancialContent Business PageReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. MarketReShape Lifesciences signed an agreement with Motion Informatics to exclusively import and distribute their neuromuscular rehabilitation devices in the U.S., including the FDA-cleared Stimel-03. The partnership aims to bring AI-driven neurorehabilitation technology to the U.S. market, with Motion Informatics' Spatial StimelMD platform combining AI, EMG biofeedback, and augmented reality.